17-(Allylamino)-17-demethoxygeldanamycin activity in human melanoma models
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2004/04/01
-
Journal
-
Indian UGC (journal)
-
Refrences31
-
Citations63
-
Angelika M. Burger
-
Heinz-Herbert Fiebig
-
Sherman F. Stinson
-
Edward A. Sausville
Cite
Burger, Angelika M., et al. “17-(Allylamino)-17-Demethoxygeldanamycin Activity in Human Melanoma Models”. Anti-Cancer Drugs, vol. 15, no. 4, 2004, pp. 377-8, https://doi.org/10.1097/00001813-200404000-00011.
Burger, A. M., Fiebig, H.-H., Stinson, S. F., & Sausville, E. A. (2004). 17-(Allylamino)-17-demethoxygeldanamycin activity in human melanoma models. Anti-Cancer Drugs, 15(4), 377-387. https://doi.org/10.1097/00001813-200404000-00011
Burger AM, Fiebig HH, Stinson SF, Sausville EA. 17-(Allylamino)-17-demethoxygeldanamycin activity in human melanoma models. Anti-Cancer Drugs. 2004;15(4):377-8.
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
You May Also Like
- Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicity
- Classification of skin cancer stages using a AHP fuzzy technique within the context of big data healthcare
- An overview and a roadmap for artificial intelligence in hematology and oncology
- Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
- The Role of Snail in EMT and Tumorigenesis
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors | Nature |
| 1,001 | 2003 |
| Plasma pharmacokinetics of a liver-selective nitric oxide-donating diazeniumdiolate in the male C57BL/6 mouse | Xenobiotica |
| 18 | 2002 |
| 10.1002/1097-0215(20010601)92:5<718::AID-IJC1257>3.0.CO;2-D | International Journal of Cancer |
| 2001 | |
| Energy Intake and Prostate Tumor Growth, Angiogenesis, and Vascular Endothelial Growth Factor Expression | CancerSpectrum Knowledge Environment |
| 148 | 1999 |
| 10.1023/A:1006382320697 | Investigational New Drugs |
| 1999 |
Refrences Analysis
The category
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens 15
is the most frequently represented among the references in this article. It primarily includes studies from Cancer Research The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Eucalyptus kino: a treasure trove of polyphenols eradicating tumors in-vivo by elevating caspase-3 level, inhibiting TGF-β and NF-κb gene expression | Natural Product Research |
| 1 | 2021 |
Spotlight on 17‐AAG as an Hsp90 inhibitor for molecular targeted cancer treatment | Chemical Biology & Drug Design |
| 64 | 2019 |
| 17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma model | PLOS ONE |
| 10 | 2018 |
| Hsp90β promoted endothelial cell-dependent tumor angiogenesis in hepatocellular carcinoma | Molecular Cancer |
| 43 | 2017 |
| CYP17A1 inhibitors in castration-resistant prostate cancer | Steroids |
| 63 | 2015 |
Citations Analysis
The category
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens 38
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Geldanamycin Analogs and was published in 2004. The most recent citation comes from a 2021 study titled Eucalyptus kino: a treasure trove of polyphenols eradicating tumors in-vivo by elevating caspase-3 level, inhibiting TGF-β and NF-κb gene expression. This article reached its peak citation in 2007, with 10 citations. It has been cited in 41 different journals, 12% of which are open access. Among related journals, the Clinical Cancer Research cited this research the most, with 10 citations. The chart below illustrates the annual citation trends for this article.